How to Taper Off Mounjaro: What Actually Happens When You Stop or Step Down

Is there a recognised medical taper schedule for Mounjaro?

The short answer is no, not in the way people often imagine. Unlike some medicines (antidepressants, corticosteroids) where a formal dose-reduction schedule is built into clinical guidance, the Mounjaro SmPC published on the eMC does not describe a tapering pathway before stopping. The licensed schedule moves doses upward during treatment; it does not specify a downward staircase for ending it.

This matters because some people assume that stopping abruptly is dangerous, or that stepping down from 15mg to 2.5mg over several months is the safe exit route. Neither assumption is well supported. The side-effect profile of stopping tirzepatide is not comparable to medicines that carry withdrawal syndromes. What does happen (and this is clinically significant) is that the appetite-suppressing and gastric-slowing effects wear off as the drug clears your system. That is a pharmacological reality, not a withdrawal effect in the traditional sense.

If you are considering stopping, the right starting point is a conversation with your prescriber. They can look at your current dose, your weight trajectory, and whether you have reached a stable point that makes stopping lower-risk. You can review the full prescribing information in the Mounjaro SmPC on the eMC, the practical detail is in there, and reading it before your consultation is a good habit.

What happens to your weight when Mounjaro is stopped?

This is the part most people are actually asking about, even when they phrase it as a question about tapering. The SURMOUNT programme, involving thousands of adults across its trials, showed clearly that weight loss on tirzepatide depends on continued treatment. When the medicine is stopped, the hormonal signals that were suppressing appetite and slowing gastric emptying disappear. Hunger returns. Food moves through the stomach faster. The physiological environment that made eating less feel natural is no longer there.

How quickly this happens varies. Tirzepatide's half-life means the drug clears gradually over roughly a week or two after the last dose, so the return of appetite is not instantaneous. But over weeks to months after stopping, the pattern seen in clinical data is a meaningful rebound in weight, not because the person has failed, but because the condition being treated (obesity) is still present.

A quick thing worth doing before your next review: note your weight on the same day each week at the same time of day. One minute, but it gives you and your prescriber a clean trend line rather than a single data point, much more useful when deciding whether stopping or stepping down is realistic.

You can read more about the wider evidence base for tirzepatide on our tirzepatide overview page.

Could stepping down doses before stopping help?

It is a reasonable hypothesis. If higher doses produce greater appetite suppression, then moving from 15mg to 10mg to 7.5mg before stopping might allow a gentler return of hunger and give someone time to consolidate new eating habits. Some clinicians discuss this approach with patients in the context of a planned, structured stop.

The honest position is that there is no robust published trial data specifically comparing stepped reduction versus abrupt discontinuation in terms of weight outcomes or tolerability. What evidence does exist on stopping GLP-1 medicines suggests that the weight regain trajectory is broadly similar regardless of how discontinuation is handled, the underlying biology reasserts itself either way, on a timescale shaped more by the half-life of the drug than by the speed of the exit.

That does not mean a step-down conversation with your prescriber is pointless. It means the conversation should be grounded in realistic expectations rather than the hope that a slower exit will protect most of the weight lost. If your goal is sustained weight management, the more productive discussion may be about whether stopping is the right decision at this point, rather than how to make stopping smoother. Our Mounjaro information page covers the full treatment picture if you want context before that consultation.

What are the practical options if you do want to stop?

People stop Mounjaro for different reasons: they have reached their goal weight and want to maintain it through lifestyle changes alone, they are facing a period where the medicine is not accessible, they are planning a pregnancy, or they have a side effect they cannot manage. Each situation calls for a different clinical conversation.

If you are planning to conceive, the guidance is clear: Mounjaro is not recommended during pregnancy or while trying to conceive, and the medicine should be stopped in advance, your prescriber will advise on timing based on the wash-out period. For other situations, the questions to work through with your prescriber are: have you reached a stable weight? Do you have the diet and activity foundations in place to maintain it? Is there a less disruptive route (such as continuing at a lower maintenance dose) that you have not yet explored? If you are also curious about how supplements interact with your treatment, our page on moringa and Mounjaro looks at that combination specifically.

There are detailed pages on the specifics of stopping Mounjaro and on weaning off Mounjaro that go further into those individual scenarios. If cost is part of your thinking, our treatment page sets out what is included in the price, which may be relevant if you are weighing whether to continue at a lower dose versus stop entirely. And if you want to understand what the period immediately after stopping looks like in practice, the coming off Mounjaro page addresses that directly.

The NHS guidance on weight management injections also notes that treatment decisions, including stopping, should be made with clinical support, a principle that applies whether you are on an NHS pathway or a private one.

If you have questions about your specific circumstances, our support team can help direct you to the right prescriber conversation. And when you are ready to review your options properly, checking your eligibility with our clinical team is the most direct next step.